Abstract
Background, aimsCognitive impairment is estimated to occur in 10–30% of systemic lupus erythematosus (SLE) patients. Its screening and early recognition is not well established in routine clinical care. Assessment tools...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
